ALB
ALB
Albemarle CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.43B ▲ | $267.46M ▲ | $319.09M ▲ | 22.33% ▲ | $2.35 ▲ | $233.51M ▲ |
| Q4-2025 | $1.43B ▲ | $154.48M ▲ | $-414.18M ▼ | -29% ▼ | $-3.87 ▼ | $211.96M ▲ |
| Q3-2025 | $1.31B ▼ | $148.07M ▲ | $-160.69M ▼ | -12.29% ▼ | $-1.72 ▼ | $134.03M ▼ |
| Q2-2025 | $1.33B ▲ | $143.13M ▲ | $22.9M ▼ | 1.72% ▼ | $-0.16 ▼ | $222.47M ▲ |
| Q1-2025 | $1.08B | $136.86M | $41.35M | 3.84% | $-0 | $181.19M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.09B ▼ | $15.14B ▼ | $5.03B ▼ | $9.85B ▲ |
| Q4-2025 | $1.62B ▼ | $16.37B ▼ | $6.59B ▼ | $9.53B ▼ |
| Q3-2025 | $1.93B ▲ | $17.15B ▼ | $6.88B ▲ | $10B ▼ |
| Q2-2025 | $1.81B ▲ | $17.29B ▲ | $6.79B ▲ | $10.24B ▲ |
| Q1-2025 | $1.52B | $17B | $6.72B | $10.03B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $328.98M ▲ | $346.24M ▼ | $540.96M ▲ | $-1.41B ▼ | $-528.19M ▼ | $247.57M ▲ |
| Q4-2025 | $-401.76M ▼ | $388.49M ▲ | $-176.64M ▼ | $-533.02M ▼ | $-313.76M ▼ | $233.1M ▲ |
| Q3-2025 | $-147.94M ▼ | $355.6M ▲ | $-152.98M ▼ | $-90.53M ▲ | $124.93M ▼ | $223.44M ▲ |
| Q2-2025 | $35.19M ▼ | $-7.2M ▼ | $362.92M ▲ | $-90.63M ▲ | $288.32M ▼ | $-126.83M ▼ |
| Q1-2025 | $49.3M | $545.38M | $-179.3M | $-120.01M | $326.28M | $362.76M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Energy Storage | $720.00M ▲ | $710.00M ▼ | $760.00M ▲ | $890.00M ▲ |
Specialties | $350.00M ▲ | $340.00M ▼ | $350.00M ▲ | $360.00M ▲ |
Ketjen | $260.00M ▲ | $250.00M ▼ | $320.00M ▲ | $0 ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Albemarle Corporation's financial evolution and strategic trajectory over the past five years.
Albemarle combines a strong strategic footprint in high‑growth lithium markets with established positions in bromine and catalysts. Historically it has shown the ability to achieve very high margins and strong operating cash flow when market conditions are favorable. The company controls valuable, diversified resource assets, benefits from vertical integration and scale, and supports these with a broad patent portfolio and active R&D program. Its substantial past investments in capacity and technology, if well utilized, provide a platform for future volume growth and product differentiation.
The most recent financial data highlight significant risks. Revenue and margins have fallen sharply from their peak, and the company is now loss‑making at the bottom line. The dramatic reported shrinkage in assets, equity, cash, and debt in 2025 suggests either a major restructuring or data/measurement issues; in any case, it raises questions about current balance‑sheet strength and business scope. Albemarle remains highly exposed to volatile commodity prices, regulatory and ESG pressures on mining and chemicals, and intense competition in global lithium markets. Heavy capital spending and ambitious R&D projects add execution and funding risk, particularly during periods of weak profitability.
Albemarle’s long‑term prospects are closely tied to the global adoption of electric vehicles, grid‑scale storage, and advanced electronics—secular trends that still appear favorable for lithium and high‑purity specialty chemicals. If the company can stabilize margins, effectively ramp its new capacity, and monetize its innovation pipeline, its structural advantages could once again translate into strong financial performance. However, the path from the current downturn to a more normalized earnings and balance‑sheet profile is uncertain and likely to be bumpy, given commodity cycles and the apparent need to digest past expansion. A clear understanding of the latest official financial statements and strategic updates will be essential to gauge how Albemarle is navigating this transition.
About Albemarle Corporation
https://www.albemarle.comAlbemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.43B ▲ | $267.46M ▲ | $319.09M ▲ | 22.33% ▲ | $2.35 ▲ | $233.51M ▲ |
| Q4-2025 | $1.43B ▲ | $154.48M ▲ | $-414.18M ▼ | -29% ▼ | $-3.87 ▼ | $211.96M ▲ |
| Q3-2025 | $1.31B ▼ | $148.07M ▲ | $-160.69M ▼ | -12.29% ▼ | $-1.72 ▼ | $134.03M ▼ |
| Q2-2025 | $1.33B ▲ | $143.13M ▲ | $22.9M ▼ | 1.72% ▼ | $-0.16 ▼ | $222.47M ▲ |
| Q1-2025 | $1.08B | $136.86M | $41.35M | 3.84% | $-0 | $181.19M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.09B ▼ | $15.14B ▼ | $5.03B ▼ | $9.85B ▲ |
| Q4-2025 | $1.62B ▼ | $16.37B ▼ | $6.59B ▼ | $9.53B ▼ |
| Q3-2025 | $1.93B ▲ | $17.15B ▼ | $6.88B ▲ | $10B ▼ |
| Q2-2025 | $1.81B ▲ | $17.29B ▲ | $6.79B ▲ | $10.24B ▲ |
| Q1-2025 | $1.52B | $17B | $6.72B | $10.03B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $328.98M ▲ | $346.24M ▼ | $540.96M ▲ | $-1.41B ▼ | $-528.19M ▼ | $247.57M ▲ |
| Q4-2025 | $-401.76M ▼ | $388.49M ▲ | $-176.64M ▼ | $-533.02M ▼ | $-313.76M ▼ | $233.1M ▲ |
| Q3-2025 | $-147.94M ▼ | $355.6M ▲ | $-152.98M ▼ | $-90.53M ▲ | $124.93M ▼ | $223.44M ▲ |
| Q2-2025 | $35.19M ▼ | $-7.2M ▼ | $362.92M ▲ | $-90.63M ▲ | $288.32M ▼ | $-126.83M ▼ |
| Q1-2025 | $49.3M | $545.38M | $-179.3M | $-120.01M | $326.28M | $362.76M |
Revenue by Products
| Product | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Energy Storage | $720.00M ▲ | $710.00M ▼ | $760.00M ▲ | $890.00M ▲ |
Specialties | $350.00M ▲ | $340.00M ▼ | $350.00M ▲ | $360.00M ▲ |
Ketjen | $260.00M ▲ | $250.00M ▼ | $320.00M ▲ | $0 ▼ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Albemarle Corporation's financial evolution and strategic trajectory over the past five years.
Albemarle combines a strong strategic footprint in high‑growth lithium markets with established positions in bromine and catalysts. Historically it has shown the ability to achieve very high margins and strong operating cash flow when market conditions are favorable. The company controls valuable, diversified resource assets, benefits from vertical integration and scale, and supports these with a broad patent portfolio and active R&D program. Its substantial past investments in capacity and technology, if well utilized, provide a platform for future volume growth and product differentiation.
The most recent financial data highlight significant risks. Revenue and margins have fallen sharply from their peak, and the company is now loss‑making at the bottom line. The dramatic reported shrinkage in assets, equity, cash, and debt in 2025 suggests either a major restructuring or data/measurement issues; in any case, it raises questions about current balance‑sheet strength and business scope. Albemarle remains highly exposed to volatile commodity prices, regulatory and ESG pressures on mining and chemicals, and intense competition in global lithium markets. Heavy capital spending and ambitious R&D projects add execution and funding risk, particularly during periods of weak profitability.
Albemarle’s long‑term prospects are closely tied to the global adoption of electric vehicles, grid‑scale storage, and advanced electronics—secular trends that still appear favorable for lithium and high‑purity specialty chemicals. If the company can stabilize margins, effectively ramp its new capacity, and monetize its innovation pipeline, its structural advantages could once again translate into strong financial performance. However, the path from the current downturn to a more normalized earnings and balance‑sheet profile is uncertain and likely to be bumpy, given commodity cycles and the apparent need to digest past expansion. A clear understanding of the latest official financial statements and strategic updates will be essential to gauge how Albemarle is navigating this transition.

CEO
Jerry Kent Jr.
Compensation Summary
(Year 2025)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2007-03-02 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 512
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
RBC Capital
Outperform
Scotiabank
Sector Outperform
Argus Research
Buy
Truist Securities
Buy
UBS
Buy
Wells Fargo
Equal Weight
Grade Summary
Showing Top 6 of 17
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:14.6M
Value:$2.58B
BLACKROCK INC.
Shares:9.96M
Value:$1.76B
CAPITAL WORLD INVESTORS
Shares:9.84M
Value:$1.74B
Summary
Showing Top 3 of 1,401

